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Objective: Although the mainstay of managing acute descending thoracic aortic dissection (ADTAD) remains medical,
certain patients will require emergency surgery for complications of rupture or ischemia. This study evaluates factors that
affect outcome and determines which patients previously treated surgically would have been eligible for endovascular
repair.
Methods: A single-institution retrospective study was conducted of patients who presented with clinical signs of ADTAD
that was confirmed by magnetic resonance angiography (MRA) or computed tomography (CT). All patients were
admitted to the intensive care unit (ICU) and medically managed to maintain systolic blood pressure <120 mmHg and
heart rate <70 beats/min. Two treatment groups were identified: group 1 received medical treatment only; group 2
received medical treatment plus emergency surgery. Patient demographic and clinical data were correlated with 30-day
group mortality and morbidity and need for emergency surgery. The MRA and CT scan images of group 2 were
retrospectively reviewed to determine if currently available endovascular treatment could have been done. The Fisher
exact test was used to compare between the groups, and P < .05 was considered significant.
Results: Between 1991 and 2005, 83 patients (55 men) were treated for ADTAD. The mean age was 67 years (range, 38
to 85). Sixty-eight patients (82%) had hypertension, three (3.6%) had Marfan syndrome, and 51 (62%) were smokers.
Twenty-five (32%) of the patients were receiving -blocker therapy before the onset of their symptoms. Back pain was the
most common initial symptom (72.2%). Emergency surgery was required in 19 patients (23%): 12 for rupture or
impending rupture, four for mesenteric ischemia, and three for lower extremity ischemia. The need for emergency surgery
was significantly higher in smokers (P .03), in patients>70 years old (P .035), and in patients whowere not receiving
-blocker therapy before the onset of symptoms (P  .023). The combined overall morbidity rate was 33%, and the
mortality rate was 9.6%. Morbidity in group 2 was 64% and significantly higher than the 23% in group 1 (P  .00227).
The mortality rate was also higher in group 2 at 31.5% compared with group 1 at 1.6% (P .0004). Factors affecting the
overall mortality included age>70 years (P  .057), previous abdominal aortic aneurysm repair (P  .018), tobacco use
(P  .039), and the presence of leg pain at initial presentation (P  .013). As determined from the review of radiologic
data, 11 of 13 patients with scans available for review in group 2 could have been treated with currently available
endovascular grafts.
Conclusions: Intensive medical therapies are effective in preventing early mortality associated with ADTAD. Predictably,
the need for emergency surgery carries a high morbidity and mortality rate. Most patients in this series requiring
emergency surgery could have been candidates for endovascular therapy had it been available. ( J Vasc Surg 2007;45:
1114-9.)Aortic dissection is one of the major vascular catas-
trophes. Since the first description in 1796 by King
George II’s personal physician,1 aortic dissection has
been well studied. Early diagnosis remains a challenge,
however, with a delay in diagnosis occurring in up to 30%
to 40% of cases.2 In the United States, the incidence of
aortic dissection is about 9000 new cases per year.3 Up to
one third of these cases involve the descending thoracic
aorta.3,4
The current standard therapy for descending thoracic
aortic dissection (ADTAD) consists of intensive medical
management with the use of -blockade, followed by vaso-
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1114dilators such as nitroglycerin or nitroprusside to reduce
heart rate and the systematic blood pressure and analgesics
to control pain. In current clinical practice, surgery is
reserved for patients who fail aggressive medical therapy or
present with complications of ADTAD such as organ or
limb ischemia, rupture, impending rupture, or progression
to aneurysmal dilatation of the aorta.
A review of the literature on early mortality in uncom-
plicated acute aortic dissection clearly favors medical man-
agement, whereas historically, emergency surgical manage-
ment of ADTAD carries a very high morbidity and
mortality rate.5 In recent years, alternative less invasive
endovascular therapy has been introduced with caution and
has been associated with encouraging results.6-9 The objec-
tives of this study are:
1. to evaluate factors that affect clinical outcomes as they
pertain to morbidity and mortality in the first 30 days
after admission for acute symptoms, including the need
for emergency surgery in the first 2 weeks from the onset
of symptoms, and
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emergency surgery for complications or failure of med-
ical therapy could have been eligible for endovascular
repair with the currently available endovascular therapy.
MATERIALS AND METHODS
This was a single-center retrospective study of patients
treated for ADTAD at theUniversity ofWisconsinHospital
and Clinics. The study was reviewed and approved by the
Institutional Review Board. All patients presenting to the
emergency department with ADTAD were admitted to the
Vascular Surgery Service. ADTAD was defined as a dissec-
tion starting distal to the origin of the left subclavian artery
without involvement of the aortic arch or its branches.
Patients were identified from medical records using diag-
nosis codes including 441.00, 401.01, 441.02, 441.03,
and 441.04. The diagnosis of ADTADwas confirmed from
magnetic resonance angiography (MRA) or computed to-
mographic (CT) imaging studies. The acuity of the diag-
nosis was based on onset of symptoms 2 weeks before
admission. Patients with radiographic evidence of ascend-
ing aortic dissection were excluded from the study.
All patients were initially admitted to the intensive care
unit (ICU) for standardized medical management with
-blocker and vasodilator medications unless there was
clinical suspicion of rupture or ischemic complications that
required immediate surgical intervention. The standard
medical management targets were to keep systolic blood
pressure 120 mm Hg and heart rate 70 beats/min and
to control pain. Patients were treated in the ICU with
intravenous administration of medications, followed by
gradual transition to oral medications.
Follow-up was scheduled at 1, 3, and 6 months, 1 year,
and every 2 years thereafter if no aneurysmal growth was
seen. The survival data were supplemented by searching the
Social Security Death Index.
Two treatment groups were identified: patients who
were successfully managed with intensive medical therapy
(group 1) and patients who required emergency surgery for
ischemic complications, rupture, or impending rupture of
the dissected aorta (group 2). Our thoracoabdominal aortic
aneurysm repair protocol has been reported previously.10
Patient demographics, clinical presentation, comorbid
conditions, use of -blockers before the onset of symp-
toms, and history of smoking were recorded. Renal dys-
function was defined as serum creatinine level of 1.5
mg/dL. These data were correlated with the 30-day mor-
bidity andmortality in each group, and factors that contrib-
uted to the need for emergency surgery were determined.
The mean length of stay in the ICU and hospital were also
compared between treatment groups.
A retrospective review of CT or MRA images in the
group 2 patients whose images were still available was also
undertaken to determine if currently available endovascular
grafts could have been used to treat these patients. This was
based on the determination of an adequate proximal aortic
neck length of ’1.5 cm and an aortic neck diameter of37
mm proximal to the primary dissection point, the goal forendovascular therapy being to seal the proximal dissection
entry and preserve true lumen patency.
Univariate analysis was performed to assess factors that
affected the overall mortality and need for emergency sur-
gery. The Fisher exact test was used for comparisons be-
tween the groups, and P  .05 was considered significant.
Kaplan-Meier survival curves were plotted to compare sur-
vival between the groups.
RESULTS
The database search identified 148 patients, and 83
patients (55 men) fulfilled the criteria for this study. The
mean age was 67 years (range, 38 to 85). Forty-two (50%)
patients presented to the emergency department within
hours of onset of symptom. The most common symptoms
included back pain (72.2%), chest pain (44.5%), abdominal
pain (30%), and leg pain (4.5%). Predictably 82% of the
patients were known to have hypertension, and 25 (32%)
were receiving -blocker therapy as part of their antihyper-
tensive regimen before onset of their symptoms. At the
time of discharge, 25 patients (40%) in group 1 were taking
four or more antihypertensive medications. Other comor-
bid conditions included coronary artery disease (CAD) in
21, diabetes mellitus (DM) in seven, and a history of
previous stroke (CVA) in eight. Only three patients (3.6%)
had a diagnosis of Marfan syndrome. Fifty-one (62%) of
patients were smokers, and 20 (24%) had history of previ-
ous abdominal aortic aneurysm repair (Table I).
Intensive medical therapy alone was successfully used
to treat 64 patients (77%; group 1), and 19 (23%) required
emergency surgery for rupture/impending rupture (n 
12) mesenteric ischemia (n  4) and lower extremity
ischemia (n 3). Of the 19 patients who required surgery,
14 (6 rupture, 3 symptomatic6 cm aneurysms, 3 mesen-
teric ischemia, and 2 extremity ischemia) were operated the
day of admission, and five patients requiring emergency
surgery were initially treated with intensive medical ther-
apy. Three of these five patients had continued chest pain
and enlargement of the aorta, one developed leg ischemia,
and one patient developed mesenteric ischemia. No inter-
vention was performed solely for renal dysfunction.
Patients aged 70 years (P  .035) and smokers (P 
Table I. Patient characteristics
Characteristic
Patients (n  83),
n (%)
Mean age, years (range) 67 (38-85)
M:F 55:28
Hypertension 68 (81.9)
Marfan syndrome 3 (3.6)
Diabetes mellitus 7 (8.4)
Renal dysfunction 4 (4.8)
CABG 7 (8.4)
CAD 21 (25.3)
CVA 8 (9.6)
CABG, coronary artery bypass graft; CAD, coronary artery disease; CVA,
cerebrovascular accident..03) were more likely to require emergency surgery. In
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their antihypertensive regimen before onset of symptoms
seemed to be protected from emergency surgery (P 
.023).
The overall 30-day mortality was 9.6% (8 deaths). Age
70 years (P .057), clinical presentation with leg pain (P
 .013), previous abdominal aortic aneurysm repair (P 
.018), and a history of tobacco use (P  .039) increased
significantly the possibility of death. Gender, presentation
with chest or abdominal pain, history of hypertension,
coronary artery disease, and history of diabetes mellitus
were not associated with an increase in the over all mortality
(Table II).
Themortality ratewas significantly higher in group2 (P
.00046) than in group 1. Two patients (1.6%) in group 1 died
from sudden cardiopulmonary arrest (no autopsy was per-
formed), and six patients died in group 2. Four of these deaths
occurred in patients who required emergency surgery for
rupture or impending rupture. Their deaths were due to
multisystemorgan failure (MSOF).One of the remaining two
patients who died presented with limb ischemia and died of
MSOF, and another who presented with mesenteric ischemia
died from hemorrhage (Table III).
The overall morbidity rate was 33% (n  27), consist-
ing of 15 in group 1 and 12 in group 2. Morbidity in group
2 was significantly higher compared with group 1 (P 
.002). Two patients in group 1 presented with paraplegia as
part of their initial symptoms. Two patients in group 2
developed paraplegia after surgery. Other morbidities in-
cluded renal failure, bacteremia, mental status changes,
Table II. Factors affecting mortality and the need for
emergency surgery
Factors
All patients
(n  83) Group 2 (n  19)
Factors affecting
mortality
Factors affecting
emergency surgery
Mortality
rate (%) P
Mortality
rate (%) P
Age
70 2.4 .05 12 .035
70 16.6 34
Gender
M 9 1 22 .7
F 10 25
Leg pain
Yes 33 .013 45 .1
No 5.6 19.7
Previous AAA repair
Yes 25 .018 26 .7
No 4.7 22
Tobacco use
Yes 14 .039 30.6 .03
No 0 9.6
-blocker
Yes 8 1 8.3 .025
No 6 32.6
AAA, Abdominal aortic aneurysm.renal dysfunction, myocardial infarction, and arrhythmias.The overall mean length of hospital stay was 14 days
and length of ICU care was 8 days. There was no significant
difference in the mean length of hospital stay (P  .1) and
ICU stay (P  .12) between the two groups.
The mean follow-up time for the cohort of patients
who survived the initial admission was 38.2 months. Dur-
ing follow-up, 18 patients (28%) required surgery for con-
tinued aneurysmal growth of the dissected aorta. Of these
elective surgery cases, 15 were performed 1 year from
onset of symptoms. The overall survival for the entire
cohort was 75%, 60%, and 49% at 1, 3, and 5 years,
respectively. For group 1 vs group 2 patients, survival was
85% vs 54% at 1 year, 64% vs 54% at 3 years, and 59% vs 18%
at 5 years (P  .002; Fig).
A review of available MRA or CT scans, or both, of the
Fig. Kaplan-Meier curves for long-term survival for group 1 (blue
line) and group 2 (red line). EMERSX, Emergency surgery.
Table III. Complications
Type of complication Group 1 (n 15) Group 2 (n12)
Paraplegia 2 2
Mental status changes 7 3*
Respiratory failure 1 2
Myocardial Infarction 4 2
Arrhythmia 2
Sepsis 1 2*
Phrenic nerve injury 1
Bleeding 2†
Cerebrovascular accident 1†
Lower extremity
ischemia
1
*Each star represents death. Of the 3 patients with mental status changes, 2
died, both patients with sepsis died as well, and 1 patient with bleeding and
1 with cerebrovascular accident died. There were a total of six deaths.
†In-hospital mortality.13 patients in group 2 revealed that 11 could have been
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vascular graft system (W. L. Gore & Assoc, Flagstaff, Ariz).
Mean aortic diameter proximal to the proximal aortic tear
was 34 mm (range, 26 to 42 mm), and coverage of the left
subclavian artery origin would have been required in five
cases to achieve an adequate proximal aortic length for seal.
DISCUSSION
ADTAD in the United States continues to be a chal-
lenging medical condition, with no significant improve-
ment in the treatment outcomes during the past several
decades. As reported by several authors, hypertension
seems to be themost common predisposing factor, whereas
dissection related to collagen vascular disease is relatively
rare.3,4 Hypertension was present in 82% of our patients,
and only 3.6% were known to have Marfan syndrome. The
clinical presentation in this study was also similar to other
reports and consisted of severe chest, back, or abdominal
pain in the presence of uncontrolled hypertension.
The gold standard for treating newly diagnosed un-
complicated ADTAD remains medical therapy, whereas
surgery is reserved for complicated presentations of
ADTAD such as visceral or limb ischemia or symptoms of
rupture or impending rupture.3 This is because of the high
morbidity and mortality rates associated with emergency
surgery in patients with ADTAD.5 Our current intensive
medical therapy protocol consists of the intravenous ad-
ministration of a -blocker, followed by a vasodilator (ni-
troglycerine) and other additional oral or parenteral anti-
hypertensive medications as needed.
Most recent reports indicate the overall mortality rate
for ADTAD to be about 10%.11 This compares favorably
with our result, where the overall in-hospital mortality rate
was 9.6%. Predictably, the mortality rate was significantly
higher if patients required emergency surgery compared
with those uncomplicated patients treated with medical
therapy alone. Similar to other reports, age 70 also ap-
peared to adversely affect overall survival and increased the
need for emergency surgery.12 Contrary to the data re-
ported by Niehuber et al,13 our study did not identify any
gender-related increase in morbidity and mortality. How-
ever, other factors that did adversely affected outcomes by
increasing overall mortality included previous infrarenal
aortic aneurysm repair, initial clinical presentation with leg
pain, and tobacco use.We have no explanation why leg pain
was associated with an increased risk of mortality, although
this may be related to a more extensive dissection.
In our series, the early mortality rate for patients who
were successfully treated medically was remarkably low
(1.6%). From these data it is difficult to justify endovascular
therapy in patients who do not develop complications at
their initial presentation. This statement seems to be sup-
ported by a report by Kato et al,14 where stent grafting of
acute dissection was associated with early and late compli-
cation rates of 33% and 36%. In contrast, early and late
complication rates of 4% and 0% were reported for similar
treatment of chronic dissections. These authors thus rec-
ommended delay in stent graft treatment of uncomplicateddissections but also suggested that endovascular therapy
may decrease the significant morbidity and mortality asso-
ciated with emergency surgery.14
Emergency surgery was required in 23% of our patients.
As indicated by several authors, mortality rates after emer-
gency surgery are very high.3,11,12,15 The high mortality
rate seen in patients requiring emergency surgery for
ADTAD demonstrated the need for an alternative, safer
approach to this complex problem.
In recent years, several reports have documented results
of the use of various endovascular therapies as a less invasive
alternative treatment for ADTAD. These include covered
stent grafting, percutaneous aortic fenestration, and aortic
branch vessel stenting.6,7,16-19 The goals of endovascular
therapy using stent grafts in ADTAD include coverage and
stabilization of the proximal dissection entry site, thrombo-
sis of the false lumen, preservation of the true lumen and
branch artery flow, and ideally, a decrease in the diameter of
the aorta.
Although there is no level I evidence on the use of
endovascular therapy for ADTAD, several reports of small
series are available. Technical success with this approach is
up to 100% in most series, and mortality rates are 6% to
10%.6,7,17 Xu et al17 recently reported successful proximal
dissection entry site sealing in up to 95.2% of patients and a
false lumen thrombosis rate of 98.4% at the 1-year follow-
up.17 In addition, Gaxotte et al16 as well as Xu reported that
when complete thrombosis of the false lumen occurred, it
resulted in a decrease in the aortic diameter, whereas partial
thrombosis was associated with continued aneurysm en-
largement.16,17 Review of CT scans and MRA of 13 patents
in group 2 in our study whose images were available re-
vealed that 11 patients could have been treated with cur-
rently the available Excluder thoracic endograft system. In
four patients, however, coverage of the origin of the left
subclavian artery would have been needed to achieve a
sufficient proximal aortic length for endograft sealing.
Patients in group 1 in our study were monitored
closely, and 28% required subsequent surgical repair. Most
of these procedures, 15 (83%) of 18, were performed 1
year from the initial presentation, suggesting the need for
very close follow up in the earlier months following
ADTAD. According to a report by Gallo et al,15 most
medically treated patients eventually require surgery for
aneurysmal growth. On the other hand, Estrera et al11
reports that only 4.3% of their patients required surgical
intervention after discharge. Regardless, as a result of our
findings we currently recommend follow-up imaging with a
CT scan or MRA at discharge, 3 and 6 months, and yearly
thereafter.
CONCLUSION
Most patients with ADTAD can initially be successfully
managed medically, and when successful, such manage-
ment is associated with a very low mortality and morbidity
rates. Careful follow-up is required, however, because up to
one third of these patients require elective intervention in
the future. In contrast, outcomes are significantly worse if
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From retrospective review of imaging studies of patients
who required emergency surgery after ADTAD in this
series, most patients could have been treated with endovas-
cular grafts, whichmight have improved outcomes. Further
clinical studies are needed to carefully assess the value of
endovascular stent grafting in the treatment of patients
requiring emergency intervention for ADTAD and the
need for endovascular stent grafting in patients with un-
complicated ADTAD.
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Dr Walter McCarthy (Chicago, Ill). Tell us now what you
have done as far as using endovascular techniques. What is your
protocol at this point? You have gone back over your data. You
have convinced yourself that youmight be able to use it. What have
you done?
Dr Girma Tefera. Thank you for the question. Since we
reviewed this data we have a protocol in place to treat an endovas-
cular patient who may present with complications requiring sur-
gery. In fact, we recently had a case of acute type B dissection with
occlusion of the aorta at the celiac artery. This patient presented
with paraplegia, anuria, and abdominal pain. We were able to open
the true lumen with balloon mounted palmaz stents deployed
across the occluded segment. Although this procedure temporarily
was successful, it reoccluded 48 hours later. The patient was then
taken to surgery for aortic replacement. Intravascular ultrasound
was very helpful in identifying the true lumen. If I am faced with a
similar situation, I will probably try to address the proximal tear
also with covered stent graft.
Dr Michael Dalsing (Indianapolis, Ind). Very nice paper, Drrepair makes things worse and that you have to operate on them
more quickly than if they do not?
Dr Tefera. The short answer to your question is, I do not
know. It is, however, interesting that this same phenomenon was
observed during thoracic endograft trials. This may have some-
thing to do with the absence of lumbar arteries in the infrarenal
aorta.
Dr JohnMatsumura (Chicago, Ill). I don’t know about why
open repair might make it risky, but I have noticed in the patients
who have an endovascular infrarenal repair who develop a thoracic
dissection that it is a very lethal combination because it tries to
stent open the true lumen, and because both legs feed off the true
lumen, oftentimes the legs create a huge outflow and increase the
chance for true lumen collapse. Roy, have you seen patients after
infrarenal repair who have type B dissection? I have seen two cases
where it is a very bad combination.
Unidentified speaker. We wrote up one case after an en-
dograft with an aortic dissection where the fixation and the seal in
the iliacs was so much stronger so that the false lumen kind of
terminates in the aneurysm sac and crushed the endograft itself.
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have not seen a lot of dissections in those endo repair patients,
infrarenal endo repairs, or open repair patients. I mean, I have
always viewed open repair as a little bit protective of dissection
because it always prevents the dissection from going down to the
iliacs but I do not know. Your data are very interesting.
Unidentified speaker.We have seen two patients with aortic
occlusion who had infrarenal aortic aneurysms and later dissection.
One was an endograft and one was a standard repair. I think it can
occur with either patient. Both were successfully treated for their
aortic occlusion with fenestration and revision. The endograft we
had to explant which was kind of a chore in the fact of an acute
dissection but it was able to be done.
Dr Jacobs–Don v Chad. I would question your conclusion.
One of them was that we should not be treating ______ currently
______ with an endograft. I am not arguing that point, but I am
not sure that your data would say that because we do not know
what they die of. With your survival curve there looking pretty
steep on these patients, I think you would have to knowwhat those
complications potentially of the dissection are down the line that
you may be able to prevent. That may be the mortality that you are
seeing in your survival group.
Dr Tefera. I think the point I indirectly wanted to make was
when you are successful treating these patients medically the
mortality rate of 1.6 is very hard to argue with because when you
see stent graft placement in dissection settings, high technical
success is reported but the mortality rate is not that low yet. That is
why I question and basically want to bring this point up, but I think
when we followed our patients, about a third them do require
elective surgery for further aneurysm expansion. We did not go
specifically to see of those who died during follow-up why they
died, but you also saw that from the curve point of view the 1-year
survival was 85% when they were successfully medically treated.Dr Roy Greenberg (Cleveland, Ohio). I think that your
results are right on in terms of the low mortality rate associated
with medical therapy for uncomplicated dissections, but some-
thing that we have struggled with is how to define optimal medical
therapy because it varies so much. So I was wondering if you had a
system for how you looked at patients. When was medical therapy
optimal and what was the drug regimen? Were they always beta-
blockers? Did you combine beta-blockers with ACE inhibitors?
How did you manage those patients?
Dr Tefera. At our institution all patients who come in with
type B dissection come to the Vascular Surgery Service, and we
basically admit all of them. Unless there is a life-threatening,
limb-threatening situation that needs to go to the operating room,
these patients will all go to the intensive care unit, have an arterial
line placed, and we have preprinted orders for esmolol drips and
nitroglycerin to be started right away. On top of that, we start of a
course oral medications to supplement. We take actually several
days of ICU stabilization prior to these patients being transferred
to the floor. In fact, if you look at the hospital length of stay for
successful medical therapy patients, it is almost the same as for
those who needed surgery. We take really our time and we have
liberal usage of the maximum dosage of esmolol and nitroglycerin,
and occasionally nitroprusside, and we transition them as quickly as
possible into an oral regimen.
Of course they all go home with a lot more oral medication
than what they had before, and we communicate with the primary
care physicians prior to their being discharged. We really take total
control, and of course medical therapy might be a failure some-
times, but it does not really occur in terms of not being able to
control the blood pressure, particularly, if you have a pseudocoarc-
tation kind of picture is rare certainly and by having these patients
on your service I think helps.
